This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (5)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Bacterial Infections  • Tuberculosis/ Other Mycobacterium  • Diagnosis  • Alert me on articles by topic  Social Bookmarking   What's this?

Sung-Han Kim, MD; Su-Jin Choi, MS; Hong-Bin Kim, MD; Nam-Joong Kim, MD; Myoung-don Oh, MD; Kang-Won Choe, MD

Arch Intern Med. 2007;167(20):2255-2259.

Background  Diagnosing extrapulmonary tuberculosis (E-TB) remains a challenge. A recently developed Mycobacterium tuberculosis–specific region of difference 1 gene-based assay for diagnosing tuberculosis infection showed promising results. However, the diagnostic usefulness of this assay remains to be determined compared with tuberculin skin test (TST) in patients with suspected E-TB in clinical practice.

Methods  All patients with suspected E-TB were prospectively enrolled in a tertiary care hospital during a 9-month period. In addition to the conventional tests for diagnosing E-TB, the interferon –producing T-cell responses to early secreted antigenic target 6 and culture filtrate protein 10 by enzyme-linked immunospot (ELISPOT) assay were performed. Final diagnosis in patients having suspected E-TB was classified by clinical category.

Results  Seventy-two patients with suspected E-TB were enrolled; 34 (47%) had immunosuppressive conditions. Of 72 patients, 32 (44%) were classified as having E-TB, including 22 with confirmed tuberculosis and 10 with probable tuberculosis, and 35 (49%) were classified as not having tuberculosis. The remaining 5 (7%) had possible tuberculosis and were excluded from the final analysis. Chronic caseating granulomas, acid-fast bacilli stain, M tuberculosis polymerase chain reaction, and cultures for M tuberculosis were positive in 22 (69%), 5 (16%), 15 (47%), and 18 (56%), respectively, of 32 patients with E-TB. The sensitivity and specificity of the TST (induration size, 10 mm) were 47% (95% confidence interval [CI], 29%-65%) and 86% (95% CI, 70%-95%), respectively. By comparison, the sensitivity and specificity of the ELISPOT assay were 94% (95% CI, 79%-99%; P < .001 between TST and ELISPOT) and 88% (95% CI, 72%-97%; P =.99 between TST and ELISPOT), respectively.

Conclusion  The ELISPOT assay is a useful adjunct test for diagnosing E-TB.

Author Affiliations: Department of Internal Medicine, Seoul National University College of Medicine (Drs S.-H. Kim, H.-B. Kim, N.-J. Kim, Oh, and Choe), and Clinical Research Institute, Seoul National University Hospital (Drs S.-H. Kim, H.-B. Kim, N.-J. Kim, Oh, and Choe and Ms Choi), Seoul, Republic of Korea.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Histologically proven isoniazid hepatoxicity in complicated tuberculous salpingitis
Semfke et al.
Ther Adv Respir Dis 2009;3:159-162.
ABSTRACT